Amgen Raises FY2026 GAAP EPS Guidance from $15.45-$16.94 to $15.62-$17.10 vs $15.18 Est

Benzinga Newsdesk www.benzinga.com Positive 93.1%

Neg 0% Neu 0% Pos 93.1%

Amgen (NASDAQ:AMGN) raises FY2026 GAAP EPS guidance from $15.45-$16.94 to $15.62-$17.10 vs $15.18 analyst estimate..

Comments

No comments yet. Be the first!